These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 21490132

  • 21. A pumpkin polysaccharide induces apoptosis by inhibiting the JAK2/STAT3 pathway in human hepatoma HepG2 cells.
    Shen W, Chen C, Guan Y, Song X, Jin Y, Wang J, Hu Y, Xin T, Jiang Q, Zhong L.
    Int J Biol Macromol; 2017 Nov; 104(Pt A):681-686. PubMed ID: 28634059
    [Abstract] [Full Text] [Related]

  • 22. Sulforaphane inhibits constitutive and interleukin-6-induced activation of signal transducer and activator of transcription 3 in prostate cancer cells.
    Hahm ER, Singh SV.
    Cancer Prev Res (Phila); 2010 Apr; 3(4):484-94. PubMed ID: 20233902
    [Abstract] [Full Text] [Related]

  • 23. Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade in vitro and in vivo.
    Rajendran P, Li F, Shanmugam MK, Kannaiyan R, Goh JN, Wong KF, Wang W, Khin E, Tergaonkar V, Kumar AP, Luk JM, Sethi G.
    Cancer Prev Res (Phila); 2012 Apr; 5(4):631-43. PubMed ID: 22369852
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro.
    Kim S, Gwak H, Kim HS, Kim B, Dhanasekaran DN, Song YS.
    Oncotarget; 2016 Dec 13; 7(50):83148-83159. PubMed ID: 27825119
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
    Chen KF, Chen HL, Liu CY, Tai WT, Ichikawa K, Chen PJ, Cheng AL.
    Biochem Pharmacol; 2012 Mar 15; 83(6):769-77. PubMed ID: 22230479
    [Abstract] [Full Text] [Related]

  • 28. Targeting C21orf58 is a Novel Treatment Strategy of Hepatocellular Carcinoma by Disrupting the Formation of JAK2/C21orf58/STAT3 Complex.
    Jiang H, Wang Y, Wen D, Yu R, Esa SS, Lv K, Feng Q, Liu J, Li F, He L, Di X, Zhang S.
    Adv Sci (Weinh); 2024 Apr 15; 11(15):e2306623. PubMed ID: 38342622
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells.
    Li F, Fernandez PP, Rajendran P, Hui KM, Sethi G.
    Cancer Lett; 2010 Jun 28; 292(2):197-207. PubMed ID: 20053498
    [Abstract] [Full Text] [Related]

  • 31. Combining celecoxib with sorafenib synergistically inhibits hepatocellular carcinoma cells in vitro.
    Morisaki T, Umebayashi M, Kiyota A, Koya N, Tanaka H, Onishi H, Katano M.
    Anticancer Res; 2013 Apr 28; 33(4):1387-95. PubMed ID: 23564777
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of STAT3 signaling pathway by ursolic acid suppresses growth of hepatocellular carcinoma.
    Liu T, Ma H, Shi W, Duan J, Wang Y, Zhang C, Li C, Lin J, Li S, Lv J, Lin L.
    Int J Oncol; 2017 Aug 28; 51(2):555-562. PubMed ID: 28714512
    [Abstract] [Full Text] [Related]

  • 33. Interferon-α and cyclooxygenase-2 inhibitor cooperatively mediates TRAIL-induced apoptosis in hepatocellular carcinoma.
    Zuo C, Qiu X, Liu N, Yang D, Xia M, Liu J, Wang X, Zhu H, Xie H, Dan H, Li Q, Wu Q, Burns M, Liu C.
    Exp Cell Res; 2015 May 01; 333(2):316-326. PubMed ID: 25724899
    [Abstract] [Full Text] [Related]

  • 34. COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells.
    Cervello M, Bachvarov D, Cusimano A, Sardina F, Azzolina A, Lampiasi N, Giannitrapani L, McCubrey JA, Montalto G.
    OMICS; 2011 Jun 01; 15(6):383-92. PubMed ID: 21410330
    [Abstract] [Full Text] [Related]

  • 35. R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells.
    Behari J, Zeng G, Otruba W, Thompson MD, Muller P, Micsenyi A, Sekhon SS, Leoni L, Monga SP.
    J Hepatol; 2007 May 01; 46(5):849-57. PubMed ID: 17275129
    [Abstract] [Full Text] [Related]

  • 36. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
    Zheng L, Yang W, Wu F, Wang C, Yu L, Tang L, Qiu B, Li Y, Guo L, Wu M, Feng G, Zou D, Wang H.
    Clin Cancer Res; 2013 Oct 01; 19(19):5372-80. PubMed ID: 23942093
    [Abstract] [Full Text] [Related]

  • 37. Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation.
    Jiang Y, Chen P, Hu K, Dai G, Li J, Zheng D, Yuan H, He L, Xie P, Tu M, Peng S, Qu C, Lin W, Chung RT, Hong J.
    J Cell Mol Med; 2021 Feb 01; 25(3):1568-1582. PubMed ID: 33410581
    [Abstract] [Full Text] [Related]

  • 38. Higher proliferation of peritumoral endothelial cells to IL-6/sIL-6R than tumoral endothelial cells in hepatocellular carcinoma.
    Zhuang PY, Wang JD, Tang ZH, Zhou XP, Quan ZW, Liu YB, Shen J.
    BMC Cancer; 2015 Nov 02; 15():830. PubMed ID: 26525581
    [Abstract] [Full Text] [Related]

  • 39. LncRNA 00152 promotes the development of hepatocellular carcinoma by activating JAK2/STAT3 pathway.
    Li SJ, Sui MH, Sun ZX, Zhang WW.
    Eur Rev Med Pharmacol Sci; 2019 Feb 02; 23(3):1038-1046. PubMed ID: 30779070
    [Abstract] [Full Text] [Related]

  • 40. A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells.
    Yeh CT, Huang WC, Rao YK, Ye M, Lee WH, Wang LS, Tzeng DT, Wu CH, Shieh YS, Huang CY, Chen YJ, Hsiao M, Wu AT, Yang Z, Tzeng YM.
    Carcinogenesis; 2013 Dec 02; 34(12):2918-28. PubMed ID: 23880305
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.